Drug recall · July 23, 2014
Diltiazem HCl Extended-release Capsules recall
Why: Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.
- Lots / codes
Lot #: 3045659, 3048256, Exp 07/14
- Quantity
- 1,184 cartons
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- Nationwide, Puerto Rico, and Guam.
- Initiated
- July 3, 2014 · Voluntary: Firm initiated
- Classified
- July 17, 2014
- Reported
- July 23, 2014
- Ended
- July 26, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diltiazem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.